SCHEMBL17169539

SCHEMBL17169539

Cc1cc(C#N)ccc1N1c2ccccc2N(c2c(C)cccc2C)[C@H]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 1/20 0.40
▸ AR P10275 3/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ EGLN2 Q96KS0 1/20 0.34
▸ CYP11B2 P19099 2/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ MDM4 O15151 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ GABRA2 P47869 1/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17169535 0.87 HTR7 (0.37) HTR7AREGLN2CYP11B2CYP11B1
SCHEMBL17169578 0.86 HTR7 (0.36) HTR7EGLN2CYP11B2GABRA1GABRG2
SCHEMBL17173455 0.85 HTR7 (0.40) HTR7AREGLN2MEN1ALDH1A1
SCHEMBL24714559 0.83 HTR7 (0.41) HTR7AREGLN2CYP11B2CYP11B1
SCHEMBL18088253 0.83 BRD4 (0.36) ARCYP1A2CYP2C19CYP11B2CYP11B1
SCHEMBL17169606 0.83 HTR7 (0.41) HTR7AREGLN2CYP11B2CYP11B1
SCHEMBL19999692 0.81 ALDH1A1 (0.39) ARMEN1ALDH1A1MAPTKMT2A
SCHEMBL21074258 0.81 ALDH1A1 (0.39) ARMEN1ALDH1A1MAPTKMT2A
SCHEMBL17952488 0.81 CASP3 (0.36) HTR7ARCYP1A2CYP2C19EGLN2
SCHEMBL17169534 0.80 HTR7 (0.39) HTR7AREGLN2MDM4MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9911928-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-03-06 — — US disclosed
US-9911928-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-03-06 — — US disclosed
US-9905785-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-02-27 — — US disclosed
US-9905785-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-02-27 — — US disclosed
US-20160276603-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-09-22 — — US disclosed
US-20160276603-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-09-22 — — US disclosed
US-20150295189-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2015-10-15 — — US disclosed
US-20150295189-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160276603-A1 Organic Electroluminescent Materials and Devices EML4, BICRA, TBCB HTR7 1804/4885AR 2937/4885CYP1A2 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback